Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Studies in western populations find that obesity and depression are positively correlated. Adipokines secreted by adipose tissue may serve as the crosstalk link between peripheral tissue and central nervous system, which mediates the relationship between obesity and depression.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>This study aimed to investigate serum retinol-binding protein 4 (RBP4) concentration in patients with major depressive depression (MDD) and clarify its possible association with depression.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Major depressive disorder patients (n = 237), healthy controls (n = 48) were collected from June 2017 to October 2019. The measurement of RBP4 levels was performed by Advia 2400 automatic biochemistry analyzer. Depressive symptoms of patients were assessed using the 24-item Hamilton Depression Scale (HAMD-24).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>(1) Serum RBP4 levels of MDD patients were significantly lower than that of the control group [(34.25 ± 8.82) mg/L vs (37.56 ± 8.83) mg/L] (<em>P</em> < 0.05) which was independent from obesity; (2) The level of RBP4 [(31.13 ± 9.16) mg/L] in suicide attempt (SA) group was significantly lower than that in the control group and non-suicide attempt (non-SA) group [(35.55 ± 8.37)mg/L](<em>P</em> < 0.05); (3) There was no significant correlation between serum RBP4 concentration and HAMD-24 score (<em>P</em> > 0.05); serum RBP4 concentrations were positively associated with age, age of onset and duration of disease (<em>r</em> = 0.325, 0.298, 0.135; <em>P</em> < 0.001, <em>P</em> < 0.001, <em>P</em> = 0.038) in depressive patients. (4) The level of serum RBP4 was positively correlated with TC, TG, and LDL-C (<em>r</em> = 0.350, 0.207, 0.268; <em>P</em> < 0.001, <em>P</em> = 0.001, <em>P</em> < 0.001), but not with other blood lipid indexes. ROC curve of RBP4 for MDD revealed an area under the curve of 0.603 and a sensitivity of 81.3%, specificity of 80%.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>The level of RBP4 in patients with MDD was lower than that in the normal control group, which might be related to the prognosis of patients with depression.</p>

Reduction in peripheral blood beta arrestin1 levels during major depressive disorder in reproductive women

Testosterone and Prolactin Perturbations Possibly Associated with Reduced Levels of β-Arrestin1 in Mononuclear Leukocytes of Women with Premenstrual Dysphoric Disorder

Increased expression of ER stress, inflammasome activation, and mitochondrial biogenesis-related genes in peripheral blood mononuclear cells in major depressive disorder

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Relaitonship of mean platelet volume to MDD: a retrospecitve study

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Increased Ratio of Mature BDNF to Precursor-Bdnf in Patients with Major Depressive Disorder with Severe Anhedonia.

Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach

Effect of Treatment on Serum Glial Cell Line-Derived Neurotrophic Factor in Bipolar Patients

Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness

Peripheral Blood BDNF-TrkB Signaling in First-Episode, Drug-Free Patients with Major Depressive Disorder and Schizophrenia.

Correlations Between Probdnf/p75ntr and Inflammatory Markers in Patients with Major Depression

Impact of antidepressant treatment on complete blood count parameters and inflammatory ratios in adolescents with major depressive disorder

Study of decreased serum levels of retinol binding protein 4 in major depressive disorder

Peripheral Alterations in Cytokine and Chemokine Levels after Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis

Lower Total Serum Protein, Albumin, and Beta- and Gamma-Globulin in Major and Treatment-Resistant Depression: Effects of Antidepressant Treatments

Analysis of blood mature BDNF and proBDNF in mood disorders with specific ELISA assays

- Individuals with major depressive disorder and inflammation exhibited sex hormone imbalance: new insights from the Biomarker in Depression (BIODEP) study

Detection of Proinflammatory Cytokines in Serum Samples from Patients with Primary Major Depressive Disorder

Upregulation of proBDNF/p75NTR signaling in immune cells and its correlation with inflammatory markers in patients with major depression

Changes in the Serum Levels of Inflammatory Cytokines in Antidepressant Drug-Naïve Patients with Major Depression